Stay updated on Tezepelumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tezepelumab in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedShow glossary UI option was added. Minor label updates include capitalization changes to 'Last Update Submitted that Met QC Criteria' and the introduction of 'No FEAR Act Data', with the revision now shown as v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor page version update with no changes to study content.SummaryDifference0.0%

- Check51 days agoChange DetectedLocations added across the US, Australia, Canada, and Europe, and several locations removed. This affects where the study is conducted and how participants can reach sites.SummaryDifference2%

- Check73 days agoChange DetectedRevision: v3.3.2 is now shown and Revision: v3.3.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision label updated to v3.3.1 and removal of v3.2.0; this is a superficial update to the page version indicator and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tezepelumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.